Is ORIG.CN undervalued or overvalued?
As of 2025-03-27, the Intrinsic Value of Origin Therapeutics Holdings Inc (ORIG.CN) is -8.00 CAD. This ORIG.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.28 CAD, the upside of Origin Therapeutics Holdings Inc is -3,010.08%. This means that ORIG.CN is overvalued by 3,010.08%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -8.00 - -8.00 | -8.00 | -3,010.08% |
| DDM - Stable | (1.39) - (2.44) | (1.91) | -796.4% |
| DDM - Multi | 0.00 - 0.00 | 0.00 | -100.0% |
| Market Cap (mil) | 1.42 |
| Beta | 3.55 |
| Outstanding shares (mil) | 5.16 |
| Enterprise Value (mil) | -1.14 |
| Market risk premium | 5.10% |
| Cost of Equity | 28.45% |
| Cost of Debt | 5.00% |
| WACC | 16.07% |